Company intelligence / Profile preview

Kunming Jida Pharmaceutical Co., Ltd.

Kunming, Yunnan, Chinaen.wxjida.com.cn ↗

Ownership: Private
Development stage: Commercial

Overview

The company has one product (Dutasteride/Tamsulosin Hydrochloride) at IND Approval stage for Prostatic Hyperplasia and another product (Cytarabine Valyl ester Hydrochloride) pending for Acute Lymphoblastic Leukemia.

Therapeutic areas: OncologyMen's Health
Modalities: Small molecules
Industry: Biotech

Beyond the preview

Go deeper on Kunming Jida Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kunming Jida Pharmaceutical Co., Ltd..

Explore the full profile